Summary

Contractile reserve and echocardiographic dyssynchrony predict early response to cardiac resynchronizatiuon therapy, according to findings from the Risk Stratification and Benefits with Cardiac Resynchronization Therapy trial [BENEFIT; NCT00996086], according to outcomes from the BENEFIT study.